AzTrials
AzTrials

FertilityNCT03121924

Effect of Timing of Oocyte Denudation Before ICSI in an Oocyte Donation Model

A study testing timing for oocyte denudation and Intracytoplasmatic Sperm injection in people with Fertility, run by Hospital Italiano de Buenos Aires at 1 site in Argentina.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Analyze the effect of preincubation time of oocyte on the results of ICSI in a oocyte donation model. Read more about this study

Who is it for?
Ages 18 to 32 years, women onlyHealthy volunteers can take part
Conditions the study is for
Fertility
What is being tested?
timing for oocyte denudation and Intracytoplasmatic Sperm injection
Could I receive a placebo?
No, everyone receives an active treatment
How many people
375 participants
Where
1 siteArgentina
Study dates
1 Dec 2015to 1 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 32 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Oocytes retrieved from healthy donors, younger than 32 years old , with proven maternity(preference), who meet the admission criteria of ovodonation program:
  • The oocytes included will be the product of antagonist stimulation protocol and with Gnrh agonists trigger. (see annex)
  • Healthy women under 50 years of age , who meet the criteria as receptors into the ovodonation program.
  • Oocytes retrieved after 36.5 h + -1 h of administration of triptorelin acetate.
  • Only mature oocytes, in stage MII, will be included and injected.
  • Use of fresh or thawed semen for the ICSI.

Who cannot join

  • Cases of severe male factor such as azoospermia or severe oligo-astheno-teratospermia( alone or combinated)
  • Sperm samples from surgical procedures (biopsy / testicular or epididymal puncture)
  • Donors with a polycystic ovarian profile, according to The Androgen Excess and PCOS Society (AES), 2006.
  • Thawed donated oocytes
  • Oocytes from patients who have previously donated within a period of less than three months.
  • Donors whith poor response (oocyte retrieved less than < 4 oocytes).
  • Suspicion or signs of Endometriosis in donor patient.

Trial locations and contacts

1 site in 1 country.

Argentina1 site
  • Hospital Italiano de Buenos Aires

    Ciudad de Buenos Aires, Buenos Aires, C1199ABB

Other trials in Argentina

About this study

Official title: Effect of Timing of Oocyte Denudation Before ICSI and Its Results in an Oocyte Donation Model: a Cluster Randomized Controlled Clinical Trial

Analyze the effect of preincubation time of oocyte on the results of ICSI in a oocyte donation model.

Read the detailed description

There is an intense communication inside the follicular structure. Bidirectional information between the oocyte and the granulosa cells is needed for a normal follicular development and oocyte competence.

There are conflicting results on the effect of pre-incubation time in ICSI.

It is not clear the proper time to denudate the oocyte from the somatic cells prior to ICSI, and some authors describe a negative impact of the premature cummulus removal on the ICSI results.

The aim of this study is to investigate wheter a preincubation time between oocyte retireval and injection has any effect on the ICSI ( intracytoplasmatic sperm injection) results .

Conditions
Fertility
Being tested
timing for oocyte denudation and Intracytoplasmatic Sperm injection
Keywords
oocyte denudation, preincubation, icsi, oocyte donation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • timing for oocyte denudation and Intracytoplasmatic Sperm injectionProcedure or surgery

    Also called cumulus corona removed, granulosa cells removed

    Donated oocytes were randomly allocated to two groups concerning the time of cumulus corona removal.

    The first group: After oocyte retrieval, cumulus cells were immediately removed and then ICSI was performed; in the second group, the oocyte-cumulus complexes were incubated for 4 hours. Afterwards, the granulosa cells were removedand ICSI was immediately performed.

Study groups in NCT03121924
Study groupRoleWhat they receive
Immediately oocyte denudationExperimentalAfter the retrieval , sybling oocytes were assigned to one o more recipient and then ,the oocytes were randomized in two arms . The first arm is the immediately denudation and immediately ICSI of the oocytes, and in the second arm the oocyte are denuded and injected after 4 hours from the pick up .
Receives: Procedure: timing for oocyte denudation and Intracytoplasmatic Sperm injection
Delayed oocyte denudationExperimentalAfter the retrieval , sybling oocytes were assigned to one o more recipient and then ,the oocytes were randomized in two arms . In this arm, the oocyte are denuded and injected after 4 hours from the pick up .
Receives: Procedure: timing for oocyte denudation and Intracytoplasmatic Sperm injection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of M2 oocytes at injection

    Asessment of the number of M2 oocytes was made after the oocyte denudation and ICSI

    Measured: four hours after oocyte retrieval

  2. Number of normal fertilized oocytes after ICSI

    Asessment of the normal fertilization rate was made 24 hours after the intervention.

    Measured: 24 hours

  3. Number of cleaving embryos

    The embryo cleavage was evaluated after 48 hours and 72 hours after the ICSI was performed.

    Measured: 72 hours

  4. Number of TOP embryos

    The embryos were morfologically classified into 4 categories . It considered TOP embryos those correctly fertilized at day 1, and with regular 6 to 8 cells at day 2 with less than 20% fragmentation and without multinuclear blastomeres.

    Measured: 72 hours

Secondary outcomes (2)
  1. Implantation rate

    The implantation rate was the ratio between the number of gestacional sacs and the number of transferred embryos.

    Measured: 14 days after embryo trasfer

  2. Clinical pregnancy rate

    Clinical pregnancy is confirmed by ultrasonography ,when one or more gestational sacs with heart activity are seen.

    Measured: 6 to 7 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2017
  2. Study start1 Dec 2015
  3. Primary completion1 Dec 2018
  4. Study completion1 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
375 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03121924
Sponsor's protocol ID
2500
Status last verified
Aug 2019
First submitted
27 Sep 2016
Last updated
1 Dec 2020
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Harrison KL, Wilson LM, Breen TM, Pope AK, Cummins JM, Hennessey JF. Fertilization of human oocytes in relation to varying delay before insemination. Fertil Steril. 1988 Aug;50(2):294-7. doi: 10.1016/s0015-0282(16)60076-6.

    PubMed 3294045
  • Jacobs M, Stolwijk AM, Wetzels AM. The effect of insemination/injection time on the results of IVF and ICSI. Hum Reprod. 2001 Aug;16(8):1708-13. doi: 10.1093/humrep/16.8.1708.

    PubMed 11473969
  • Rienzi L, Ubaldi F, Anniballo R, Cerulo G, Greco E. Preincubation of human oocytes may improve fertilization and embryo quality after intracytoplasmic sperm injection. Hum Reprod. 1998 Apr;13(4):1014-9. doi: 10.1093/humrep/13.4.1014.

    PubMed 9619563
  • Van de Velde H, De Vos A, Joris H, Nagy ZP, Van Steirteghem AC. Effect of timing of oocyte denudation and micro-injection on survival, fertilization and embryo quality after intracytoplasmic sperm injection. Hum Reprod. 1998 Nov;13(11):3160-4. doi: 10.1093/humrep/13.11.3160.

    PubMed 9853875
  • Yanagida K, Yazawa H, Katayose H, Suzuki K, Hoshi K, Sato A. Influence of oocyte preincubation time on fertilization after intracytoplasmic sperm injection. Hum Reprod. 1998 Aug;13(8):2223-6. doi: 10.1093/humrep/13.8.2223.

    PubMed 9756300
  • Ho JY, Chen MJ, Yi YC, Guu HF, Ho ES. The effect of preincubation period of oocytes on nuclear maturity, fertilization rate, embryo quality, and pregnancy outcome in IVF and ICSI. J Assist Reprod Genet. 2003 Sep;20(9):358-64. doi: 10.1023/a:1025476910771.

    PubMed 14531646
  • Hassan HA. Cumulus cell contribution to cytoplasmic maturation and oocyte developmental competence in vitro. J Assist Reprod Genet. 2001 Oct;18(10):539-43. doi: 10.1023/a:1011901923261.

    PubMed 11699125

Questions about this trial

What is this clinical trial studying?

A study testing timing for oocyte denudation and Intracytoplasmatic Sperm injection in people with Fertility, run by Hospital Italiano de Buenos Aires at 1 site in Argentina.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Argentina. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of M2 oocytes at injection (time frame: four hours after oocyte retrieval). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03121924, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in